Predictive biomarkers of ipilimumab toxicity in metastatic melanoma.

Michael Gowen,Jeremy Tchack,Hua Zhou,Keith M. Giles,Scott Paschke,Una Moran,David Fenyö,Aristotelis Tsirigos,Michael Pacold,Anna C. Pavlick,Michelle Krogsgaard,Iman Osman

Predictive biomarkers of ipilimumab toxicity in metastatic melanoma.

2017

Michael Gowen
Jeremy Tchack
Hua Zhou
Keith M. Giles
Scott Paschke
Una Moran
David Fenyö
Aristotelis Tsirigos
Michael Pacold
Anna C. Pavlick
Michelle Krogsgaard
Iman Osman

9559Background: There are no predictive biomarkers of ipilimumab (IPI) toxicity. Of metastatic melanoma (MM) patients (pts) receiving IPI (3mg/kg), 35% require systemic therapies to treat immune-re...

Keywords:

Melanoma
Ipilimumab
Toxicity
Biomarker (medicine)
Pathology
Medicine
metastatic melanoma
predictive biomarker
Oncology
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations